Skip to content

Can nutrition education reduce undernutrition and disease severity in adolescents with sickle cell disease?

Sickle Cell Nutrition (SCeDi) Project: Effect of a nutrition education programme on nutritional status and disease severity of adolescents with sickle cell disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN17054215
Enrollment
470
Registered
2019-03-18
Start date
2018-11-06
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sickle cell disease Haematological Disorders

Interventions

Adolescents attending the four selected hospitals will be randomized into either an intervention or control group. Every adolescent and their caregiver who meets the inclusion criteria will be contact

Sponsors

Carnegie-University of Ghana BANGA Project
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adolescents aged 10-19 years 2. Confirmed diagnosis of SCD and who are appropriately described to be ‘in a steady state’ (no history of stroke or long-term transfusion therapy for at least 4 weeks before the intervention, no hospitalization or intercurrent illness that required emergency or hospitalization 4 weeks before the study) 3. No other chronic disorder

Exclusion criteria

Exclusion criteria: Receiving any treatment that has a direct impact on growth e.g. hydroxyurea

Design outcomes

Primary

MeasureTime frame
Percentage change in fat-free mass assessed using a bioelectrical impedance analyzer device (Omron (BF511) and the Fourier-transform infrared spectroscopy instrument, which determines the percentage fat and fat-free mass at baseline and 6 months

Secondary

MeasureTime frame
1. Knowledge, Attitude, Practices and Perception (KAPP) scores of all the adolescents using the FAO KAPP questionnaire 2. Disease Severity Index Scores calculated from number of recurrences (frequency of painful crises, hospitalization and blood transfusion over the past 6 months), laboratory values (haemoglobin level, bilirubin level, proportion of foetal haemoglobin (HbF), lactate dehydrogenase (LDH) level and leucocyte count) and disease complications (acute chest infection/syndrome, leg ulcers, gallstones, stroke, avascular osteonecrosis, osteomyelitis, enuresis, priapism, retinopathy, and deep vein thrombosis) 3. Stunting (height for age) assessed using using WHO AnthroPlus software 4. Wasting (weight for height) assessed using using WHO AnthroPlus software 5. Underweight (weight for height) assessed using using WHO AnthroPlus software 6. Nutrient intake and dietary diversity scores assessed using 24-hour recall and Food Frequency Questionnaire analyzed using the Esha FPro 3.2 and RIING database All outcome measures were measured at baseline and endline (6 months).

Countries

Ghana

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026